JPS6434921A - Preventive and remedy for thrombosis - Google Patents

Preventive and remedy for thrombosis

Info

Publication number
JPS6434921A
JPS6434921A JP62190769A JP19076987A JPS6434921A JP S6434921 A JPS6434921 A JP S6434921A JP 62190769 A JP62190769 A JP 62190769A JP 19076987 A JP19076987 A JP 19076987A JP S6434921 A JPS6434921 A JP S6434921A
Authority
JP
Japan
Prior art keywords
thrombosis
remedy
preventive
protease
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62190769A
Other languages
Japanese (ja)
Inventor
Kiyotaka Okazaki
Susumu Sakamoto
Mikio Furukawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP62190769A priority Critical patent/JPS6434921A/en
Publication of JPS6434921A publication Critical patent/JPS6434921A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PURPOSE:To provide an easily administrable preventive and remedy for thrombosis, exhibiting excellent effect even by oral administration and having low toxicity and side effect, by using a protease free from plasminogen activator activity as an active component. CONSTITUTION:A protease free from plasminogen activator activity, preferably a protease having an optimum pH of 5-9 (e.g. chymotrypsin, subtilicin, thermolysin or papain) is used as an active component. The compound is preferably administered at a rate of 150-300 Azocoll unit for adult in one or several divided doses. It exhibits excellent anticoagulation and thrombolytic actions by oral administration.
JP62190769A 1987-07-30 1987-07-30 Preventive and remedy for thrombosis Pending JPS6434921A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62190769A JPS6434921A (en) 1987-07-30 1987-07-30 Preventive and remedy for thrombosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62190769A JPS6434921A (en) 1987-07-30 1987-07-30 Preventive and remedy for thrombosis

Publications (1)

Publication Number Publication Date
JPS6434921A true JPS6434921A (en) 1989-02-06

Family

ID=16263416

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62190769A Pending JPS6434921A (en) 1987-07-30 1987-07-30 Preventive and remedy for thrombosis

Country Status (1)

Country Link
JP (1) JPS6434921A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0659443A1 (en) * 1993-12-24 1995-06-28 Sun Medical Technology Research Corporation Sealing system of an artificial internal organ

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0659443A1 (en) * 1993-12-24 1995-06-28 Sun Medical Technology Research Corporation Sealing system of an artificial internal organ

Similar Documents

Publication Publication Date Title
ATE101524T1 (en) PHARMACEUTICALLY ACTIVE COMPOUND CONTAINING HIRUDIN AND ACTIVATOR OF PLASMINOGEN.
TR199801151T2 (en) Drugs that inhibit thrombin.
DE69228106D1 (en) HIV protease inhibitors
CO4750598A1 (en) PROCEDURE FOR THE ENZYMATIC TREATMENT OF COCOA AND COMPOSITION OBTAINED THROUGH THE SAME
NO962017L (en) 5,6-Dihydropyrone - derivatives such as protease inhibitors and antivirals
DZ1766A1 (en) HIV protease inhibitors useful for the treatment of AIDS.
ATE252081T1 (en) NEW HIV PROTEASE INHIBITORS
IL205695A0 (en) Compositions containing dspa alpha 1 for the treatment of stroke
EP0714435A4 (en) PRO-UROKINASES OBTAINED BY MUTATION
FI914995A0 (en) THERAPEUTIC AEMNE.
DK0729463T3 (en) 5,6-Dihydropyrone derivatives as protease inhibitors and antivirals
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
JPS6434921A (en) Preventive and remedy for thrombosis
EP0351246A3 (en) A tissue plasminogen activator analogue
ATE103178T1 (en) T-PA PRO STABILIZATION.
GB1414696A (en) Protease inhibitor and a method for its production
DE69000290D1 (en) THROMBOTIC COMPOSITIONS.
SU1119668A1 (en) Method of treatment of chronic pancreatitis
GEP20032923B (en) Sulphonamide Derivatives as Prodrugs of Aspartyl Protease Inhibitors, Pharmaceutical compositions containing the Same and Methods for Treatment